Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

Effects of Psychosocial Skills Training on Self-Stigma and Forgiveness Among Caregivers of Individuals With Psychotic Disorders (RUTBE)

14 november 2026 bijgewerkt door: Ömer USLU

The Effects of Psychosocial Skills Training on Self-Stigma and Forgiveness Among Caregivers of Individuals With Chronic Mental Illness: A Randomized Controlled Trial

This randomized controlled trial aims to evaluate the effects of psychosocial skills training on self-stigma and forgiveness among family caregivers of individuals with psychotic disorders. Caring for a person with a long-term mental illness can create emotional and social challenges. Family caregivers may experience stigma, difficulties in social relationships, and challenges related to forgiveness.

The study will include 34 adult caregivers who will be randomly assigned to an intervention group (n=17) or a control group (n=17). The intervention group will receive an eight-session, face-to-face psychosocial skills training program delivered once a week. The program will focus on understanding mental illness, improving communication and problem-solving skills, supporting treatment, managing persistent symptoms, coping with stress, and strengthening social functioning. The control group will not receive the training during the study period.

Self-stigma and forgiveness will be assessed in both groups before the intervention, immediately after the eight-session program, and three months after the intervention. The findings will help determine whether psychosocial skills training can reduce self-stigma and improve forgiveness among caregivers of individuals with psychotic disorders.

Studie Overzicht

Toestand

Nog niet aan het werven

Gedetailleerde beschrijving

This study is designed as a two-arm, parallel-group randomized controlled trial to investigate the effects of psychosocial skills training on self-stigma and forgiveness among caregivers of individuals diagnosed with psychotic disorders. The study will be conducted at the Community Mental Health Center affiliated with Söke Fehime Faik Kocagöz State Hospital in Aydın, Türkiye.

A total of 34 caregivers will be recruited and randomly allocated to an intervention group (n=17) or a control group (n=17) using randomizer.org. Eligible participants will be adults aged 18 years or older who are literate and provide care to an individual diagnosed with a psychotic or schizophrenia spectrum disorder according to DSM-5 criteria. Caregivers whose conditions substantially interfere with effective communication will not be eligible. Participation will be voluntary, and informed consent will be obtained before data collection.

The intervention group will participate in a structured psychosocial skills training program based on the principles of Liberman's Social and Independent Living Skills Program and the training manual developed by Yıldız. The program will consist of eight weekly, face-to-face group sessions lasting approximately 90-120 minutes each. The sessions will address group preparation and communication, understanding mental illness and daily living skills, cognitive and perceptual disturbances, treatment and medication management, coping with persistent symptoms and early warning signs, avoiding harmful or ineffective treatments, stress management and self-confidence, and social functioning. Interactive discussions, practical exercises, and homework assignments will be used to support learning and application of skills. Homework reminders may be provided by telephone calls or messages.

The control group will not receive the structured psychosocial skills training during the intervention and follow-up periods. Following completion of the three-month follow-up assessment, the training will also be offered to the control group.

Data will be collected at three time points: baseline, immediately after completion of the eight-session intervention, and three months after the intervention. The Self-Stigma Scale-Family Form will be used to assess caregivers' self-stigma, and the Forgiveness Scale will be used to assess forgiveness. A personal information form will be administered at baseline to collect sociodemographic characteristics.

The study will compare changes in self-stigma and forgiveness scores between the intervention and control groups over time. The findings are expected to provide evidence regarding the potential benefits of structured psychosocial skills training for caregivers of individuals with psychotic disorders.

Studietype

Ingrijpend

Inschrijving (Geschat)

34

Fase

  • Niet toepasbaar

Contacten en locaties

In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.

Studiecontact

Studie Locaties

    • SÖKE
      • Aydin, SÖKE, Turkije (Türkiye), 09200
        • Söke Fehime Faik Kocagöz State Hospital - Community Mental Health Center

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

18 jaar en ouder (Volwassen, Oudere volwassene)

Accepteert gezonde vrijwilligers

Ja

Geslachten die in aanmerking komen voor studie

Allemaal

Beschrijving

Inclusion Criteria:

  • Being 18 years of age or older.
  • Being a family caregiver of an individual diagnosed with a psychotic or schizophrenia spectrum disorder.
  • Being able to read and write.
  • Being willing to participate in the study and providing informed consent.

Exclusion Criteria:

  • Having a condition that prevents effective communication or participation in the study procedures.

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

  • Primair doel: Ondersteunende zorg
  • Toewijzing: Gerandomiseerd
  • Interventioneel model: Parallelle opdracht
  • Masker: Geen (open label)

Wapens en interventies

Deelnemersgroep / Arm
Interventie / Behandeling
Experimenteel: Experimental Group

Participants in this group will receive an eight-session, face-to-face psychosocial skills training program delivered once weekly. Each session will last approximately 90-120 minutes.

The intervention consists of eight weekly, face-to-face psychosocial skills training sessions for family caregivers of individuals with psychotic disorders. Each session will last approximately 90-120 minutes. The program focuses on mental illness awareness, communication, problem-solving, treatment support, symptom management, stress management, and social functioning.

Geen tussenkomst: Control Group

Participants in this group will not receive the structured psychosocial skills training program during the intervention and follow-up periods. The training will be offered after completion of the three-month follow-up assessment.

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Change in Caregiver Self-Stigma
Tijdsspanne: Baseline, immediately after the 8-week intervention, and 3 months after the intervention

Caregiver self-stigma will be assessed using the Self-Stigma Scale-Family Form, a 14-item instrument rated on a five-point Likert scale. Changes in self-stigma scores will be compared between the intervention and control groups across three assessment points.

Baseline, immediately after the 8-week intervention, and 3 months after the intervention
Change in Caregiver Forgiveness
Tijdsspanne: Baseline, immediately after the 8-week intervention, and 3 months after the intervention

Forgiveness will be assessed using the Forgiveness Scale, a 13-item instrument rated on a seven-point Likert scale. Changes in forgiveness scores will be compared between the intervention and control groups across three assessment points.

Baseline, immediately after the 8-week intervention, and 3 months after the intervention

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Sponsor

Onderzoekers

  • Hoofdonderzoeker: Hava Salık, PhD, Hakkari University

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start (Geschat)

1 december 2026

Primaire voltooiing (Geschat)

31 mei 2027

Studie voltooiing (Geschat)

31 mei 2027

Studieregistratiedata

Eerst ingediend

14 november 2026

Eerst ingediend dat voldeed aan de QC-criteria

14 november 2026

Eerst geplaatst (Werkelijk)

19 november 2026

Updates van studierecords

Laatste update geplaatst (Werkelijk)

19 november 2026

Laatste update ingediend die voldeed aan QC-criteria

14 november 2026

Laatst geverifieerd

1 november 2026

Meer informatie

Termen gerelateerd aan deze studie

Plan Individuele Deelnemersgegevens (IPD)

Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?

NEE

Beschrijving IPD-plan

Individual participant data will not be shared with other researchers due to the sensitive nature of the psychosocial information collected from family caregivers of individuals with psychotic disorders and the need to protect participant confidentiality and privacy. Study findings will be reported in aggregate form without identifying individual participants.

Informatie over medicijnen en apparaten, studiedocumenten

Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel

Nee

Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct

Nee

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .

Abonneren